study question: Are maternal progesterone levels in early pregnancy associated with fetal birthweight? summary answer: Low levels of first-trimester maternal progesterone are significantly associated with a reduction in birthweight in girls, but not boys.
Introduction
During the second half of the 20th century, the mean birthweight increased in Western countries (Alexander et al., 1996; ChikeObi et al., 1996; Skjaerven et al., 2000; Oishi et al., 2004) . However, surveillance data suggest that this upward trend in mean birthweight is currently reversing (Branum and Schoendorf, 2002; Ananth et al., 2004; Ferre et al., 2011) . Birthweight is a strong predictor for the short-term survival of newborns (Cnattingius et al., 1998; Chen et al., 2011) as well as an indicator for the long-term health outcome (Wilcox and Russell, 1983; Osmond et al., 1993; Wilcox, 2001; Friedlander et al., 2003) . For example, children born with a reduced birthweight or small for gestational age show an increased risk for diseases, such as cardiovascular disease Osmond et al., 1993; Eriksson et al., 2000; Huxley et al., 2007) , hypertension (Curhan et al., 1996; Law and Shiell, 1996) , type 2 diabetes (Lithell et al., 1996; Pilgaard et al., 2010) , obesity (Curhan et al., 1996) , asthma (Chatkin and Menezes, 2005; Nepomnyaschy and Reichman, 2006; Ortqvist et al., 2009; Kindlund et al., 2010) and atopic dermatitis (Steffensen et al., 2000) as well as psychopathologies (Botting et al., 1997; Betts et al., 2011; Boyle et al., 2011; Lund et al., 2011) . Many of these diseases currently experience an unprecedented rise (Robison et al., 1999; Bach, 2002; Wild et al., 2004; Asher et al., 2006) . Thus, these recent observations merit a timely re-evaluation of risk factors altering birthweight.
A variety of different factors to which a woman is exposed to during pregnancy can result in reduced birthweight. These factors include altered maternal nutrition (Hales and Barker, 2001; Okubo et al., 2012) , exposure to organic solvents (Ahmed and Jaakkola, 2007) , excessive physical strain (Woo, 1997; Vrijkotte et al., 2009) , psychosocial stressors (Wadhwa et al., 1993; Dominguez et al., 2005; Borders et al., 2007; Eskenazi et al., 2007; Mortensen et al., 2009) as well as smoking during pregnancy (Horta et al., 1997; Bernstein et al., 2005; Hammoud et al., 2005 ).
Yet, insights on how, for example, maternal nutrition, physical strain or psychosocial stress affects birthweight are largely elusive. The main mechanisms under investigation are changes in the maternal immune and endocrine systems. These systems are pivotal in maternal adaptation to pregnancy and, hence, fetal development (Challis et al., 2009; Golightly et al., 2011) . In addition, both systems are sensitive to environmental challenges (Arck et al., 2001; Douglas, 2010; Parker and Douglas, 2010; Douglas, 2011) .
During pregnancy, the maternal immune system adapts to the fetal semi-allograft and creates a pregnancy protective immune milieu (Challis et al., 2009) . Progesterone is essential to promoting this immunological adaptation to pregnancy (Szekeres-Bartho et al., 2001; Schindler, 2004; Di Renzo et al., 2005; Arck et al., 2007; Piccinni, 2007; Karimi et al., 2008) . It is secreted by the corpus luteum in early gestation, whereas in later stages of the first trimester, its production shifts to the placenta (Stites and Siiteri, 1983) . Unsurprisingly, low levels of serum progesterone have been associated with an abnormal pregnancy outcome, such as miscarriage (McCord et al., 1996; Arck et al., 2008) . In sheep, low progesterone levels have been associated with low lamb birthweight (Wallace et al., 1997 ), yet evidence arising from human studies to sustain the association between maternal progesterone and birthweight is still scarce. Mucci et al. (2003) observed in a cohort study with 230 participating women that maternal progesterone levels during the third trimester of pregnancy could be related to increases in birthweight.
Environmental challenges can also affect the endocrine system, which may be of particular significance during pregnancy. It has been reported in both human and animal studies that levels of progesterone are decreased by environmental challenges, such as stress (Nepomnaschy et al., 2004; Arck et al., 2008; Creel et al., 2009) , smoking (Ng et al., 2006) or dithiothreitol exposure (Chedrese and Feyles, 2001) .
To date, no insights into progesterone levels during the first trimester of pregnancy and subsequent birthweight are available. Therefore, we addressed this lack of knowledge in the present study. If a link between first-trimester endocrine imbalances and birthweight at term can be identified, a window for therapeutic options to prevent a reduced birthweight may open. Thus, we hypothesize that maternal factors, such as endocrine adaptation, e.g. levels of progesterone, hold a central switchboard position during pregnancy, as they are sensitive to environmental insults and may affect birthweight. Since published data from human and murine studies suggest a sex difference with regard to the effect of progesterone in prenatal programming of allergic diseases (Jago et al., 2010; Pincus et al., 2010) , we further wanted to explore sex-specific effects of maternal factors on birthweight. The primary aim of this study was thus to explore the relationship of progesterone and estradiol with birthweight. In addition, our goal was to uncover associations between environmental and maternal factors and progesterone levels. We tested these objectives employing data from a prospective pregnancy cohort study.
Materials and Methods

Subjects and study design
Pregnant women were enrolled in a prospective cohort study by the Department of Internal Medicine and Psychosomatics and the Department of Obstetrics at the Charité University Medicine in Berlin (Elsenbruch et al., 2007; Arck et al., 2008) . They were recruited through 99 obstetricians in private practice in Berlin, Germany. Pregnancy was confirmed by a positive hCG blood or urine test between 4 and 12 weeks of gestation, subsequently confirmed by the ultrasonic detection of the fetal heart rate. Women who were under the age of 18, who had a gestational age beyond 12 weeks and who had used progesterone supplementation or fertility treatments were excluded from the study. All women provided written informed consent. The study was approved by the ethics committee of the Charité University Medicine, Berlin.
Medical, socio-demographic and psychosocial data and obstetrical and gynecological history were documented at recruitment during the first trimester. After delivery, data on the perinatal outcome and pregnancy complications were collected. The follow-up was accomplished by placing a prestamped card in the pregnancy passport upon recruitment. Such a pregnancy passport is standardized throughout Germany and handed out to every pregnant woman at the time of confirmation of pregnancy. Participating women were asked to register perinatal outcomes, documented in the pregnancy passport, by sending the completed card to the study coordinators. In addition, obstetricians kept a separate perinatal outcome card on file and sent it back upon knowledge of the pregnancy outcome. The study's initial aim was to identify if and how challenges during early pregnancy, e.g. high-stress perception, poor social support or hormonal alterations, increase the risk for subsequent pregnancy complications, e.g. miscarriage or pre-eclampsia. A sample size of 892 cases at a power of at least 80% to detect significant differences was determined .
Women who miscarried or had an elective abortion or those with pregnancy complications, such as fetal malformations, pregnancy-induced hypertension, pre-eclampsia/HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome, gestational diabetes, placental abnormalities, preterm birth as well as maternal diseases, infections and multiple births, were excluded from these analyses (see Supplementary data, Table SI , for a detailed list). In total, progesterone could be measured for 906 women who participated in the study and fulfilled these criteria. Data from the follow-up were collected from 623 study participants. This high attrition rate is likely due to women moving or changing doctors during pregnancy. Further, these data were confirmed in 494 cases by the respective physician. Among these 79.3% of cases, where information was obtained from study participant and physician, the recorded data did not differ with regard to the parameter of interest, except in wording, though the women's written accounts in text fields were more detailed. Based on the independent confirmation of the women's data in 79.3% of all cases, we assumed that a self-reporting bias can be largely neglected in the remaining 20.7% of cases and included all 623 women in our analyses. Fourteen of these women had a baby with a birthweight under 2500 g.
Pregnancy complications and perinatal outcomes
The perinatal outcome card included information on delivery, such as gestational age at delivery, method of delivery, sex, weight and length of the neonate and information on pregnancy complications, including miscarriage, pregnancy-induced hypertension, pre-eclampsia/HELLP syndrome, fetal growth restriction, gestational diabetes and other complications.
Progesterone and estradiol measurement
Blood was taken by venous puncture from all women at the recruitment visit in private practice during the first trimester of pregnancy. It was delivered by courier to the laboratory within 1-3 h. Serum was harvested from cell blood samples after centrifugation (1100 g/20 min) and stored at 2808C until further use. Serum progesterone and estradiol concentrations were later assayed using an enzyme-linked immunosorbent assay kit (DRG, Instruments GmbH, Marburg, Germany). Serum samples were thawed and steroids extracted and assayed according to the manufacturer's protocol.
Assessment of maternal factors
During the recruitment visit in the first trimester, gestational age, smoking during pregnancy, maternal age and body mass index (BMI) and medical history were thoroughly recorded. Gestational age at this time was determined based on the first day of each woman's last menstrual period. Medical history, such as the number of pregnancies, miscarriages and births, was recorded. We refrained from using available data on gravidity due to a potential lack of accuracy. Additionally, women's psychosocial and emotional functioning was assessed with standardized questionnaires evaluating stress perception and symptoms of depression.
Stress perception was measured using a previously validated 20-item German short version of the perceived stress questionnaire (PSQ; Levenstein et al., 1993; Fliege et al., 2005) . It yields a sum score as well as subscores for worry, tension, demands and joy.
The women's depressive symptoms were evaluated with a short version of the validated German version of the 'Center for Epidemiological Studies Depression Scale' (Radloff, 1977; Hautzinger and Bailer, 1993) called 'Allgemeine Depressionsskala' (Hautzinger and Bailer, 1993) .
Statistical analyses
Continuous variables were calculated as the mean and SEM, which were used for data presentation. Comparisons between groups, such as women with continuous participation versus discontinued participation and baby boys versus girls, were carried out with the independent sample t-test for continuous data, since they were normally distributed, and the x 2 test for categorical data. The distribution of the continuous factors, maternal age and BMI were divided into categories defined by cutoffs-supported by diagnostic criteria if applicable-for further analyses. Progesterone and estradiol levels were expressed in ng/ml and standard deviations by transforming hormone levels into z-scores depending on gestational age. To determine whether progesterone affects birthweight, univariable and multivariable linear regression analyses were employed, since progesterone and birthweight were normally distributed. Residuals scatterplots were examined to assess whether assumptions of linear regression were met. Possible confounding factors in the relationship between progesterone and birthweight were identified based on previous publications: maternal age and BMI, maternal smoking, previous successful pregnancies and maternal stress. Since progesterone, as well as estradiol, varied linearly with gestational age, all multivariable models are statistically adjusted for gestational age (a linear term). Similarly, gestational age at delivery was adjusted for in multivariable analyses predicting birthweight. Correlation coefficients were used to identify multicollinearity between predictors. A correlation coefficient of .0.80 was set as a threshold. When possible multicollinearity was detected, the variable with the lower regression coefficient was excluded from the multivariable model.
To explore the effect of environmental and maternal factors on progesterone, univariable regression analyses were performed to indicate crude relationships with progesterone. To construct the final multivariable regression model, forward stepwise linear regression was performed. A liberal criterion for entry and exclusion of predictors was chosen at P ¼ 0.15 and P ¼ 0.20, respectively.
Due to the exploratory nature of these analyses, no Bonferroni corrected level of significance for the number of tests performed was used. The Bonferroni method decreases the type I error and consequently increases the likelihood of type II errors, which among other reasons is why its use is not always recommended (Perneger, 1998) . Since the aim of this study was to uncover new associations and relationships, disregarding a potentially important association was deemed more problematic and a P-value of ,0.05 is considered statistically significant in all analyses, None of the P-values can be interpreted as error probabilities in a confirmative sense. All statistical analyses were performed with SPSS 19.0 (SPSS Inc., Chicago, IL, USA).
Results
First, we determined whether participants, who due to their continued participation until birth were included in the analyses (n ¼ 623), were representative of the entire sample or whether they differed from those who did not participate in the follow-up (n ¼ 283). Available characteristics of both groups are described in Supplementary data, Table SII. The two groups were compared in all characteristics collected at recruitment during the first trimester. Significant differences in maternal BMI, gestational age at recruitment, maternal smoking and previous successful pregnancies were found (Supplementary data, Table SII ). More women who dropped out were smokers and had previous successful pregnancies. In addition, they were recruited at an earlier gestational age and had a lower BMI. This indicates selective attrition in some maternal characteristics, which are associated with birthweight and progesterone level. No selective attrition in the measures of main interest, maternal progesterone, estradiol, perceived stress and depressive symptoms is evident.
Effects of progesterone on birthweight
The association of maternal progesterone and estradiol with birthweight irrespective of the child's sex was assessed in univariable regression analyses. Neither progesterone nor estradiol was significantly associated with overall birthweight (Supplementary data, Table SIII ). Next, we aimed to determine whether the child's sex modified the association of progesterone and birthweight by creating a model with an interaction term. The interaction term significantly predicted the birthweight, b ¼ 0.16, P ¼ 0.01, and its addition to the model significantly improved the overall model fit (F for change in R 2 ¼ 7.04, P ¼ 0.01). The term remained significant (b ¼ 0.12, P ¼ 0.01) after further adjustment of the model for confounding factors based on the literature, e.g. gestational week at progesterone assessment, gestational week at birth, smoking during pregnancy, maternal BMI and age, previous successful pregnancies, perceived worry, sex and progesterone. We proceeded by analyzing the effect of maternal factors on birthweight stratified by child's sex to examine this interaction further. Here, a significant crude positive association of the progesterone level during the first trimester and birthweight was detected in girls, but not boys (Table I ). For each ng/ml increase in progesterone, the birthweight in girls increased by 12.71 g (95% CI: 2.89 -22.53 g; see Supplementary data, Table SIV , for unstandardized regression coefficients and 95% CIs). Similarly, each standard deviation increase in progesterone increased birthweight by 90.9 g (95% CI: 28.86-152.93 g). Scatterplots visualize this crude relationship between progesterone levels and birthweight in girls in comparison with boys ( Fig. 1) . Interestingly, estradiol was not significantly associated with birthweight in either sex (Table I) . However, the perception of worries by the mother during the first trimester was associated with a lower birthweight if the woman was pregnant with a girl. Smoking during early pregnancy significantly lowered birthweight exclusively in boys (Table I) . As expected, previous successful pregnancies had a significant positive association with birthweight in both girls and boys. All relevant confounders based on the literature were included in the subsequent generation of a multivariable model. This model was adjusted for gestational age at assessment and delivery.
The significant positive effect of the maternal progesterone level on birthweight in girls remained in the adjusted multivariable analysis (Table II ). An analysis with changes in progesterone expressed in standard deviations confirms these results (Supplementary data, Table SV ). The inverse relationship between the PSQ worries subscale and birthweight in girls remained statistically significant. In addition to perceived worries and previous successful pregnancies, maternal progesterone was the only other factor assessed during the first trimester associated with birthweight in girls. With a similar effect strength as in the girls, previous successful pregnancies also positively affected birthweight in boys. Smoking during pregnancy remained only negatively associated with birthweight in boys, but not girls.
To take the shift in progesterone production from corpus luteum to the placenta into account, we analyzed the effect of the progesterone level in women dependent on gestational age at data acquisition. Here, we differentiated cases in which progesterone levels were assessed between 4 and 8 weeks of gestation or between 9 and 12 weeks of gestation. The results indicate a stronger effect of placental progesterone on birthweight in girls and no significant effect of progesterone in boys (Table III, data on boys not shown).
Next, we determined whether maternal markers significantly differed by child's sex. Here, we compared maternal demographic, anamnestic, biological and psychosocial factors and newborns' birthweight. The only significant difference between boys and girls was a higher birthweight in boys (Supplementary data, Table SVI ).
Determinants of the progesterone level
As we identified levels of progesterone during early pregnancy as a predictor for birthweight in girls, we then aimed to determine which environmental and maternal factors influence progesterone. We here considered maternal age, BMI, previous successful pregnancies, child's sex and smoking as well as the psychosocial factors, stress and depressive symptoms as predictors for levels of progesterone in univariable regressions. None of the psychosocial factors influenced maternal progesterone levels in our analyses (Supplementary data, Table SVII ). However, high maternal BMI (25 -30 or .30), maternal age between 18 and 21 and smoking during pregnancy all significantly lowered progesterone levels.
A final multiple regression model was constructed using statistical stepwise regression. Due to possible multicollinearity between PSQ score and PSQ worries subscore, only the worries subscore was included in this model building process. This multivariable model included maternal BMI and maternal age and was corrected for gestational age at progesterone assessment (Table IV) . In this adjusted model, only maternal BMI and young maternal age had a significant association with progesterone levels. A maternal BMI between 25.0 and 30.0 or over 30.0 was associated with reduced levels of progesterone, compared with women with a BMI between 18.5 and 25 in the first trimester. Further, maternal age between 18 and 21 years reduced progesterone by 2.19 ng/ml (95% CI: 23.96 to 20.42 ng/ml) compared with an age between 22 and 28. Neither smoking during pregnancy nor psychosocial factors, stress and depressive symptoms provided additional prediction of levels of progesterone and were excluded from the model. These results were independently confirmed using progesterone expressed in standard deviation (data not shown). Thus, no effect of environmental factors on progesterone was found.
Discussion
Levels of progesterone in maternal serum analyzed during the first trimester were positively associated with birthweight, if the woman was pregnant with a girl. Each increase of progesterone by 1 ng/ml altered girls' fetal weight by 10.17 g (95% CI: 2.03 -18.31 g), after controlling for confounding factors. This association between maternal levels of progesterone and birthweight could not be detected in women who carried a boy. Here, maternal smoking during early pregnancy predicted reduced birthweight, irrespective of progesterone. Previous successful pregnancies had a significant positive relationship with birthweight in both girls and boys, which is in agreement with published data (Andersson et al., 2000; Fadeev et al., 2011) .
In our cohort, no association between environmental challenges such as perceived stress, depressive symptoms or smoking and changes in progesterone during the first trimester could be detected. Though maternal smoking was initially related to decreases in progesterone (Supplementary data, Table SVI), only maternal factors, such as BMI and age, significantly affected progesterone after mutual adjustments in the multivariable analysis. Maternal BMI over 25, as well as maternal age between 18 and 21, significantly reduced the maternal progesterone, which is in accordance with previous research (Wuu et al., 2002; Toriola et al., 2011) .
Our results unveil a positive effect of maternal progesterone levels in early gestation on birthweight in girls, but not boys. Since no effect of fetal sex on progesterone levels could be determined and progesterone levels did not differ by sex, this sex-specific effect may indicate sex-specific placental function. Transfer of nutrients across the placenta is a major aspect of placental function and affects fetal growth. This transfer is greatly influenced by placental imprinting of maternal and paternal genes (Reik et al., 2003) . These genes likely interact with hormones and binding proteins, which modulate their expression, to control fetal nutrient supply and demand. Evidence suggests sex-specific differences in placental gene expression that go beyond just X and Y chromosome-linked genes (Sood et al., 2006) . These differences could be responsible for the sex-specific changes in fetal growth in response to progesterone and this presumed association should be tested in future studies.
Published data indicate a link between maternal stress perception and reduced levels of progesterone, which we could not detect in our present study (Nepomnaschy et al., 2004) . It is possible that we missed this link in our cohort, as we employed the PSQ, which records very little information on quality and quantity of stressors. More detailed information on timing, type and severity of stressors may be needed to more clearly elucidate the relationship of environmental stressors with progesterone, which we are currently addressing in an ongoing birth cohort. Mediating processes of an interaction between stress and progesterone should also be taken into account. The effect of stress on progesterone levels and the female reproductive system is mediated by inhibitory effects of the hypothalamus -pituitary-adrenal (HPA) axis. Inadequate concentrations of progesterone in early pregnancy are linked to the stress-mediated activation of the HPA axis and subsequent increases in corticotrophin-releasing hormone (CRH) and glucocorticoid concentrations (Antonijevic et al., 2000; Padgett and Glaser, 2003) . To better assess effects of psychological stressors on progesterone interactions with the HPA axis should be taken into consideration and indicators of its activity, such as CRH or cortisol, should be measured in addition to progesterone.
Smoking during pregnancy reduced birthweight in boys, but not girls. Though many studies report that smoking reduces birthweight (Hammoud et al., 2005; Lelong et al., 2011) , to our knowledge, no study describes sex-specific effects of tobacco smoke. Tobacco smoke affects placental and fetal gene expression related to biological processes involved in fetal growth (Votavova et al., 2011) . Through fetal imprinting these effects may be moderated by fetal sex.
Clearly, it would have been desirable to consider the effect of, for example, continuous smoking during the second or third trimester compared with discontinued smoking beyond the first trimester on birthweight, as maternal smoking during the entire gestational length is associated with reduced growth in fetal head circumference, abdominal circumference and femur length (Jaddoe et al., 2007) . Similarly, excessive maternal weight gain opposed to physiological weight gain during pregnancy could affect fetal birthweight (Siega-Riz et al., 2009). Our study design did not include such information, a limitation which we have addressed in a currently ongoing prospective birth cohort.
In conclusion, maternal progesterone in the first trimester appears to be a good indicator of fetal growth in women pregnant with a girl, but not with a boy. Further studies are needed to confirm these results and investigate the mechanisms of progesterone and why this effect is sex-specific. More detailed assessment of environmental challenges and the effect of other endocrine mediators are necessary to determine which factors influence progesterone levels and how. We propose that the effects of progesterone on birthweight should be examined in depth in future studies, as screening of maternal progesterone could be anticipated as a valuable tool to predict pregnancies at risk to result in the birth of a girl with low birthweight. 
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